Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Science. 2021 May 21;372(6544):808-814. doi: 10.1126/science.abf7958. Epub 2021 Apr 15.
Obesity is a global epidemic that causes morbidity and impaired quality of life. The melanocortin receptor 4 (MC4R) is at the crux of appetite, energy homeostasis, and body-weight control in the central nervous system and is a prime target for anti-obesity drugs. Here, we present the cryo-electron microscopy (cryo-EM) structure of the human MC4R-G signaling complex bound to the agonist setmelanotide, a cyclic peptide recently approved for the treatment of obesity. The work reveals the mechanism of MC4R activation, highlighting a molecular switch that initiates satiation signaling. In addition, our findings indicate that calcium (Ca) is required for agonist, but not antagonist, efficacy. These results fill a gap in the understanding of MC4R activation and could guide the design of future weight-management drugs.
肥胖是一种全球性的流行病,会导致发病和生活质量受损。黑皮质素受体 4(MC4R)是中枢神经系统中食欲、能量平衡和体重控制的核心,是抗肥胖药物的主要靶点。在这里,我们展示了与激动剂 setmelanotide 结合的人 MC4R-G 信号复合物的冷冻电镜(cryo-EM)结构,setmelanotide 是一种最近被批准用于肥胖治疗的环状肽。这项工作揭示了 MC4R 激活的机制,强调了启动饱腹感信号的分子开关。此外,我们的发现表明钙(Ca)是激动剂而不是拮抗剂效力所必需的。这些结果填补了对 MC4R 激活理解的空白,并可能为未来的体重管理药物的设计提供指导。